Dr Yadi Gorji, MD in Egg Harbor Township, NJ - Pathology

Dr Yadi Gorji, MD is a Pathology - Anatomic Pathology & Clinical Pathology physician based in Egg Harbor Township, New Jersey. Dr Yadi Gorji is licensed to practice in New Jersey (license number 27744) and his current practice location is 42 Lacosta Dr, Egg Harbor Township, New Jersey. He can be reached at his office (for appointments etc.) via phone at (609) 601-8522.

NPI number for Dr Yadi Gorji is 1013933829 and his current mailing address is 42 Lacosta Dr, Egg Harbor Township, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013933829.

Contact Information

	Dr Yadi Gorji, MD
	42 Lacosta Dr, Egg Harbor Township, NJ 08234-5839
	(609) 601-8522
	Not Available

Physician's Profile

Full Name	Dr Yadi Gorji
Gender	Male
Speciality	Pathology - Anatomic Pathology & Clinical Pathology
Location	42 Lacosta Dr, Egg Harbor Township, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013933829
Provider Enumeration Date: 07/14/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Yadi Gorji such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013933829	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	27744 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Yadi Gorji is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Yadi Gorji, MD 42 Lacosta Dr, Egg Harbor Township, NJ 08234-5839 Ph: (609) 601-8522	Dr Yadi Gorji, MD 42 Lacosta Dr, Egg Harbor Township, NJ 08234-5839 Ph: (609) 601-8522

News Archive

TessArae's RM-Flu test granted FDA EUA

TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.

Multiplication of ecDNA genes present in many cancer types, drives poor patients outcomes

The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including Professors Vineet Bafna and Dr.Paul Mischel of the University of California San Diego and Professor Roel Verhaak of Jackson Laboratories.

Maturation process plays more of a role in learning and development of college students

How well young people learn and develop during their college years may be due more to the normal process of maturing rather than the college experience itself, according to a new student assessment tool developed by researchers at Indiana State University.

Tips to help ensure best plastic surgery results

Believe it or not, you play just as big a role in the overall success of your cosmetic surgery as your surgeon. Board certified plastic surgeon Dr. Gregory A. Buford recently published a comprehensive list of tips to help ensure the best results, no matter what procedure you're preparing for.

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.

Dr Yadi Gorji, MD - Pathology in Egg Harbor Township, NJ